The table below shows Xenon Pharmaceuticals Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$300.94M
$210.39M
$167.51M
$105.77M
$75.46M
$50.52M
SG&A
$79.63M
XENE annual revenue (10-K history)
Xenon Pharmaceuticals Inc. reported annual revenue of $311.00K for fiscal year 2017. That is down 82.8% from $1.80M in fiscal 2016. Over the 6 fiscal years shown, annual revenue declined from $14.31M (FY 2012) to $311.00K. Figures come from the company's audited annual reports as filed with the SEC.